The Latest Breaking News from Oncology

Cancer is one of the most devastating diseases, affecting thousands of people every year. That is also why it is one of the most well-researched areas of healthcare, with medical professionals constantly looking for ways to adapt the latest technology developments to improve cancer detection and treatments

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care…

World’s largest cancer conference in Chicago shares ‘impressive’ findings in vaccines, drug trials and AI

‘They didn’t even try to make it work,’ one oncology patient said of Memorial Medical Center

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs, increasing demand for innovative medications, and technological advancements. Therefore, fundamentally strong pharmaceutical stocks Dr. Reddy’s (RDY), Teva Pharmaceutical Industries (TEVA), and AbbVie (ABBV) could be worth adding to your portfolio. Read on.

The breakthroughs in cutting-edge medical technologies for cancer care are remarkable. It seems like every day we are reading about ground-breaking progress that can change the fundamental premise of medical care delivery. Wearable technology, molecular testing and point-of-care devices promise hospital-level care at home, but established technologies like robotic surgery…

Despite its outsized year-to-date gains, Wall Street expects this breakout penny stock to soar 55% higher, on average.

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster drugs in its pipeline, this should bode well for growth at AZN.

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

The c-word strikes most people like a thunderbolt, impacting the psyche as a disease with no cure and very dismal chances of survival. Fortunately, recent advancements in medication and technology have significantly increased the survival rate of cancer patients worldwide. Even in cases where cancer is detected at a later…